GlassScriptPhysician profile
Casey L Edwards
NPI 1245587393
$5,015.27
in general payments reported to CMS, 2019-2025
41 companies · $617 in 2025
The $617 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,115 · 2022: $1,040 · 2023: $257 · 2024: $986 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,860.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,071.77 | 2021-2025 | |
| Novo Nordisk INC | $625.98 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $495.78 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $308.44 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $255.26 | 2021-2025 | |
| Amgen INC. | $215.84 | 2021-2022 | |
| Recor Medical INC | $161.98 | 2025 | Paradise Ultrasound Renal Denervation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.16 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $147.92 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $143.40 | 2021-2022 | |
| Amarin Pharma, INC. | $140.82 | 2021 | |
| Exact Sciences Corporation | $118.38 | 2024-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $99.34 | 2021-2024 | Arexvy, Shingrix |
| Astellas Pharma US INC | $77.32 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $72.77 | 2021-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.